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Background: The isoflavonoid genistein represents the major active compound from soybean, the vegetal product
from Glycine max (Fabaceae). The aim of this study is to prove that genistein was incorporated in two semisynthetic
cyclodextrins, beta-cyclodextrin derivatives: hydroxypropyl-beta-cyclodextrin and randomly-methylated-beta
-cyclodextrin as well as to compare the anti-inflammatory activity of genistein with that of genistein incorporated in
these two types of semisynthetic cyclodextrins.
Results: The animal studies were conducted on 8-week old C57BL/6 J female mice. Inflammation was induced in
both ears of each mouse by topical application of 10 micrograms 12-O-tetradecanoylphorbol-3-acetate dissolved in
0.1 ml solvent (acetone : dimethylsulfoxide in a molar ratio 9:1). Thirty minutes later treatment was applied. The
inflammatory reaction was correlated with increased values in ear thickness. Treatment with genistein and genistein
incorporated in the two cyclodextrins led to decreased values for ear thickness. Better anti-inflammatory action was
found for the complexes of genistein. Both haematoxylin-eosin analysis and CD45 marker expression are in
agreement with these findings.
Conclusions: Results allow concluding that genistein is an active anti-inflammatory phytocompound and its
complexation with hydrophilic beta-cyclodextrin derivatives leads to a stronger anti-inflammatory activity.
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Flavonoids (flavus= yellow) are a class of secondary
plant metabolites which function mainly as vegetal pig-
ments, as antibiotic defence substances and as signal
molecules for beneficial micro organisms in the rhizo-
sphere [1]. Researchers continue to find new functions
for this class of compounds, such as components of a
healthy human diet [1,2].
The isoflavonoid genistein (Gen) (4’, 5, 7-trihydroxyisofla-
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reproduction in any medium, provided the orrepresents a major active compound from soybean [2], the
vegetal product from Glycine max (Fabaceae). Previous
studies have demonstrated that genistein possesses many
biological functions, such as preventive of coronary heart
disease and osteoporosis, antioxidant, antineoplasic and
anti-inflammatory compound [3-6].
Inflammation is a localized reaction of tissues in re-
sponse to an aggressive action, characterized by redness,
warmth, swelling, pain, and sometimes loss of mobility
or function. Inflammation is considered a beneficial and
necessary attempt of the organism to eliminate the ag-
gressive agent and to start the healing process, which
can consist in suppression of tumour initiation or pro-
gression. As a consequence, when the control mechan-
ism of inflammation does not function properly and the
inflammation persists, diseases including cancer mayral Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and




Figure 1 Chemical structure of genistein.
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genistein and other flavonoids exhibit an anti-
inflammatory effect both for human and mouse skin, as
well as inhibitory action against the activation of nuclear
factor-kB and secretory phospholipase A2 [9-11].
Genistein shows a high solubility in organic solvents
such as dimethylsulfoxide (DMSO), dimethylformamide,
acetone and ethanol. Due to its chemical structure, it
has, however, a very poor solubility in water, which dras-
tically reduces its bioavailability [12]. Inclusion com-
plexes are nowadays largely used in the pharmaceutical
field in order to optimize the solubility, chemical stabil-
ity and bioavailability of guest molecules. Recently, much
interest has focused on cyclodextrins (CD), because of
their remarkable ability to form host–guest inclusion
complexes with a wide variety of molecules, changing
the physical-chemical properties of the guests [13,14].
β-cyclodextrin derivatives are cyclic oligomers formed
by seven units of glucose via α-(1,4)-linkages, having a
toroidal shape with hydrophobic cavity and hydrophilic
exterior. Due to this specific structure, they act as mo-
lecular hosts for a large variety of guest molecules,
both polar and non-polar, through non-covalent inter-
actions [14].
The aim of this study is to compare the anti-inflammatory
activity of genistein with the one of genistein incorporated
in two ramified beta-cyclodextrins: hydroxypropyl-;beta-
cyclodextrin (HPBCD) and randomly–metylated-beta-cyclo-
dextrin (RAMEB); cyclodextrin-genistein products were
physical-chemically analysed by X-ray diffraction, thermal
analysis and electronic microscopy in order to evaluate the
formation of real inclusion complexes. The study intends to
examine the correlation between the increased water solu-
bility of genistein, due to complexation, and its anti-
inflammatory activity on animal model.
Results and discussion
Genistein-β-CD complexes were previously prepared, as
reported in the literature [15], mainly through the inser-
tion of the guest A-ring into the cyclodextrin cavity. The
complexes of genistein with the natural beta-cyclodextrin
proved a higher solubility and bioavailability compared tothe drug alone [16]. Considering the rather low water
solubility of natural β-CD, studies have been conducted
on the complexation of genistein with derivatisedcyclo-
dextrins [17]. To the best of our knowledge, no studies
have been performed on the biological properties (i.e.
anti-inflammatory activity) of genistein complexes with
semisynthetic hydrophilic derivatives of β-CD.
Complexes were analysed by X-ray diffraction, differ-
ential scanning calorimetry (DSC) and scanning electron
microscopy (SEM) in order to establish the true inclu-
sion nature of the final product.
Figure 2 shows the diffraction patterns for genistein
and its products with HPBCD and RAMEB. Genistein
presents three major peaks at 2θ values of 7.51°, 12.78°
and 24.81° with a range of smaller peaks accompanying
them. Both cyclodextrins, HPBCD and RAMEB, show
no crystallinity at all, having an amorphous structure.
All the characteristic peaks of genistein are highly
reduced in case of genistein 1:2 products indicating a
partial amorphisation of the product. The peak at 2θ
value of 18.14° shifts at 18.09° in HPBCD complex. The
peak at 2θ value of 19.33° disappears completely at
RAMEB complex and shifts at 19.23° in case of HPBCD
complex, while the peak at 2θ value of 21.13° disappears
in both cyclodextrin complexes. Two new peaks appear
in case of HPBCD complex: at 2θ values of 14.83° and
20.97°, indicative of an interaction between the drug and
the cyclodextrin, accompanied by intimate changes of
the lattice level. There is also a shift of the peak at 2θ
value of 28.84° at 28.76° and 28.79° in case of HPBCD
and RAMEB complexes, respectively. The shifts of the
peaks’ position and the appearance of new peaks in the
XRD patterns of genistein products indicate the possibil-
ity of formation of a solid form with different properties
or inclusion complexes.
DSC analysis was used in order to reveal the inter-
action between the drug and its host molecules, HPBCD
and RAMEB. When guest molecules are trapped inside
cyclodextrin cavities, their physical-chemical para-
meters (such as melting, boiling, sublimation points)
change: they either disappear or shift to other tem-
peratures [18].
The DSC plot of pure genistein shows a crystalline
state with a sharp endothermic peak at 303.66°C
(ΔH=142.73 Jg-1) (Figure 3), which is attributed to its
melting process. In the thermograms of both cyclodex-
trins no peaks were observed, confirming their amorph-
ous structures; both cyclodextrins decompose above
300°C. For both cyclodextrins, a broad endothermic
band was observed at around 100°C, which was related
to the dehydration process. For the simple physical mix-
tures of pure genistein and cyclodextrins, thermograms
showed a superposition of both components, with a partial
amorphisation of the final products (not shown). The DSC
Figure 2 X-ray diffraction patterns. (a) genistein; (b) genistein: HPBCD; (c) genistein: RAMEB; (d) HPBCD; (e) RAMEB.
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RAMEB, respectively, showed the complete disappearance
of genistein fusion peak, indicating the formation of
amorphous aggregates and the possibility of inclusion com-
plex formation between the two substances. The complexes
decompose above 300°C, similar to the pure cyclodextrins,
a further evidence of the inclusion of genistein into the
cyclodextrins’ matrices.
The scanning electron microscopy images (Figure 4 a, b,
c) show a difference between the morphology of the pure
substance genistein compared to its two complexes with
HPBCD and RAMEB, respectively. This analysis confirmsthe fact that the complexation took place and physical
interactions were produced.
Genistein consists of large, pure crystals with a smooth
surface and a regular prismatic shape. The size of tetrag-
onal particles is between 5–30 μm. The SEM pictures re-
veal the morphological changes of the crystals after
complexation: the regular, smooth surface disappeared,
and, because of the interaction between the drug and
cyclodextrins, following the preparation procedure, ag-
gregation can be seen. The cyclodextrins presumably
cover the surface of genistein. HPBCD and RAMEB are
amorphous materials and complexation agents, therefore
Figure 3 DSC thermograms. (a) genistein; (b) HPBCD; (c) RAMEB; (d) gen-HPBCD; (e) gen-RAMEB.
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tein is presumable. The regular shape of the drug is also
affected; the amorphous HPBCD and RAMEB can be
seen on the particle surface.
In order to be able to compare the anti-inflammatory ac-
tivity of soy isoflavonoid genistein, which has already been
confirmed by previous studies [9-11], to the one of genis-
tein incorporated in HPBCD and RAMEB, inflammation
was induced using the mouse ear model for inflammation
and ear thickness was measured. Results presented inFigure 4 SEM pictures. a - Gen; b - Gen: HPBCD; c - Gen: RAMEB.Figure 5 indicate that the topical application of 10 μg 12-O-
tetradecanoylphorbol-3-acetate (TPA) dissolved in 0.1 ml
solvent (acetone : DMSO in a molar ratio 9:1) to both the
inner and outer ear surfaces causes a significant increase in
ear thickness after 24 hours: (0.52±0.06 mm) compared to
the one of mice in the blank group (0.21±0.01 mm). Ex-
perimental groups treated with genistein alone or incorpo-
rated in CDs showed significantly reduced ear oedema
compared to group B, where TPA alone was applied on
the mice ear. In case of treatment with pure genistein,
Figure 5 Differences between ear thicknesses in the six groups.
Figure 6a - Values for oedema after induction of
inflammation and treatment; b - Inhibitory ratio (%) of tested
compounds.
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0.40±0.03 mm. Smaller values, and therefore better anti-
inflammatory response, was found in case of treatment with
the complexes: genistein : HPBCD (0.35±0.04 mm) and
genistein : RAMEB (0.34±0.06 mm). Indomethacin was
used as control and the average value of ear thickness in
this case was 0.29±0.04 mm. After measuring ear thickness
for each group, values for oedema and inhibitory rate were
calculated (Figure 6 a, b). The average value for oedema
induced by TPA alone was 0.31±0.06 mm, IR=0%, while
the average value for oedema in case of treatment with gen-
istein was 0.19±0.03 mm, IR=38.71%; for the CD-
complexes of genistein, the measured average values of
oedema were: 0.14±0.04 mm, IR=54.83% (HPBCD) and
0.13±0.06 mm, IR=58.06% (RAMEB). Indomethacin led
to average values of 0.08±0.04, IR=74.19%. These results
allow to draw the conclusion that genistein has an anti-
inflammatory activity which becomes stronger for its com-
plexes with hydrophilic CDs, but the values are smaller
than in case of positive control using indomethacin.
After weighing the ears, morpho-pathological analyses
were performed. Results can be seen in Figure 7 a - f.
Figure 7a presents histological aspect of a normal tissue
while Figure 7b lays out changes in the tissue after inflam-
mation was induced: massive oedema of the superficial and
deep dermis, major destruction of the superficial dermis and
complete lyses of the muscular layer were detected. Acute
inflammation occurs in two overlapping stages: vascular and
cellular. Oedema, an established marker of acute in-
flammation is present due to an increased blood vessel
wall permeability followed by plasma extravasation
[19-21]. Neutrophils ar capable of direct lyses of muscle cell
membranes through a superoxide-dependent mechanism
[22,23]. Data suggest that topical application of 10 μg TPA
dissolved in 0.1 ml solvent to the inner and outer surfacesof the ear is a reliable and easily reproducible model for
acute inflammation in experimental animals [24-26].
When genistein was applied, Figure 7c, massive oedema
of the deep dermis was still present but only a partial de-
struction of the superficial dermis and of the underlying
muscle cells could be detected. Inhibition of TPA-induced
inflammation might be associated with the genistein’s cap-
acity to suppress the production of reactive oxygen species
and other inflammatory mediators [3]. Results are consist-
ent with the findings of other groups: Bandara et al. [10]
underlined the anti-inflammatory activity of topical isofla-
vonoids, using UVB irradiation to induce inflammation in
Figure 7 Histological analysis. a) Normal tissue - Group A (HE×200); b) Massive oedema of the superficial and deep dermis. Major destruction
of the superficial dermis. Complete lyses of the muscular layer- Group B (HE×200); c) Massive oedema of the deep dermis. Partial destruction of
the superficial dermis. Partial destruction of the underlying muscle cells- Group C (HE×200); d) Rich polymorphous inflammatory infiltrate that
increases in thickness the sub epithelial dermis without inflammatory infiltrate in epithelial tissue-Group D (HE×200); e) Epithelial and cartilaginous
tissue with marked edema Group E (HE×200); f) Loose stroma, oedematous, with low cellularity-Group F (HE×200).
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effect of soy isoflavone extract from soybean cake for the
protective effects against UVB-induced damage, including
inflammation. An improved anti-inflammatory activity of
genistein was detected when genistein was incorporated in
the two β-CDs. In case of the complex genisten : HPBCD,
Figure 7d, haematoxylin-eosin (H&E) analysis detected a
rich polymorphous inflammatory infiltrate that increased
in thickness the sub epithelial dermis without the presence
of an inflammatory infiltrate in the epithelial tissue, while in
case of the complex genistein : RAMEB, Figure 7e, H&E
analysis detected an epithelial and cartilaginous tissue with
marked oedema. Inclusion complexes of cyclodex-
trins with nonpolar drugs represent a topic of high
interest in pharmaceutical research, for providing thepossibility to increase the water solubility, stability
and bioavailability of the guest drugs [14,17,28,29].
Genistein bioavailability can be increased by complexation
with CDs [30]. Zhao et al. [31] found an enhanced bioavail-
ability of soy isoflavones by complexation with two com-
mercially available dendrimers.
For the control group, mice treated with indomethacin,
Figure 7f, a loose stroma, oedematous, with low cellularity
was detected. Indomethacin is a consecrated typical non-
steroidal anti-inflammatory compound [32,33].
In order to observe some of the cellular events, more
specific migration of leucocytes at the site of injury, ex-
pression of the marker CD45 was analysed (Figure 8 a-f).
CD45, a transmembranar leukocyte-specific protein tyro-
sine phosphatase, is an abundant cell surface glicoprotein
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modulates the function of the haematopoietic cells. CD45
is also called the common leukocyte antigen [34,35]. Be-
cause inflammation is characterised by a transfer of
plasma and leucocytes from the blood into the damaged
tissue [36], CD45 is a good marker to differentiate the de-
gree of inflammation. Acute inflammation is mediated by
granulocytes, mainly neutrophils [37,38] while macro-
phages together with lymphocytes are involved in the pro-
duction mechanism of chronic inflammation [39,40]. In
this study one can observe the weak expression of CD45
in case of group A, blank, and group F, mice treated with
indomethacin, a classical anti-inflammatory compound
[32,33] in contrast with the strong expression of the mar-
ker in case of group B, mice on which TPA in acetone was
administered. Due to an increased presence of leucocytes
in this group, again one can confirm that TPA is a good
inductor of inflammation. The expression of the marker isFigure 8 Expression of the marker CD45 in the different groups (x 40
f)- Group F.reduced in case of group C, mice treated with genistein,
compared to group B, but higher than the expression in
group F. This allows us to assert that genistein possesses
anti-inflammatory proprieties, but milder than the ones of
indomethacin. Regarding the presence of leucocytes in
case of group D, mice treated with genistein incorporated
in HPBCD, and group E, mice treated with genistein
incorporated in RAMEB, their number is quite similar
with slight increased values in case of group E. In both
cases the expression is weaker than in case of group C,
confirming again the findings that genistein incorporated
in β-CDs presents a greater bioavailability, translated in a
stronger anti-inflammatory effect.
Conclusions
As conclusion, genistein can be reconsidered as an active
anti-inflammatory phytocompound on C57BL/6 J animal
model. Complexation of this active phytocompound with0). a)- Group A; b)- Group B; c)- Group C; d)- Group D; e)- Group E;
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stronger anti-inflammatory activity, proving to be a good
method to improve the water solubility of genistein in
order to obtain a better therapeutic response. These
findings are of special interest since pharmaceutical for-
mulations that produce increased drug concentration at




Genistein was purchased from Extrasynthese (France,
purity >95%), hydroxylpropyl-beta-cyclodextrin (HPBCD)
and randomly-metylated-beta-cyclodextrin (RAMEB) from
Cyclolab Hungary, 12-O-tetradecanoylphorbol-13-acetate
(TPA) from Sigma Aldrich, Germany. All substances were
used as received.
Preparation of complexes
Different methods were applied for the preparation of
the inclusion complexes:
 simple powder mixing, using a mortar and a pestle;
 kneading with a 50% (w/w) water : ethanol solution
until the bulk of solvent evaporated and a paste-type
product was formed; the mixture was then dried at
room temperature for 24 hours and put in the oven,
at 105°C, for several hours until reaching constant
weight. The final product was pulverized and sieved.
All the binary products were prepared using 1:2 genis-
tein : CD molar ratio (MwGen = 270,25, MwHPBCD = 1396,
MwRameb = 1303). The molar ratio of 1:2 was chosen in
order to achieve a better water solubility for genistein.
Differential scanning calorimetry (DSC)
The DSC measurements were made with a Mettler To-
ledo DSC 821e thermal analysis system with the STARe
thermal analysis program V9.1 (Mettler Inc., Schwerzen-
bach, Switzerland). Approximately 2–5 mg of genistein
or its product was examined in the temperature range
between 25°C and 350°C. The heating rate was 5°C min-1.
Argon was used as carrier gas, at a flow rate of 10 l h-1
during the DSC investigation.
Scanning electron microscopy (SEM) assay
The shape and surface characteristics of genistein and
complex were visualized using a scanning electron
microscope (Hitachi S4700, Hitachi Scientific Ltd.,
Japan). The samples were sputter coated with gold–
palladium under an argon atmosphere using a gold
sputter module in a high vacuum evaporator and the
samples were examined using SEM set at 15 kV.X-ray diffraction
X-Ray-diffraction patterns were obtained on a Philips
PW 1710 diffractometer, where the tube anode was Cu
with Kα= 1.54242 Å. The pattern was collected with a
tube voltage of 50 kV and 40 mA of tube current in step
scan mode (step size 0.035, counting time 1 s per step).
Animal studies
Ethical statement: The work protocol followed all
NIAH-National Institute of Animal Health rules: animals
were maintained during the experiment in standard condi-
tions: 12 h light–dark cycle, food and water ad libitum,
temperature 24°C, humidity above 55%. The experiment
was conducted according to the rules of the Ethical Com-
mittee of UMF “Victor Babes” Timisoara.
Animal studies were conducted on 8-week old C57BL/
6 J female mice. Mice were purchased from Charles
River (Sulzfeld, Germany). The number of mice included
in the study was forty-eight (48), divided into six groups
as follows:
– group A: blank group
– group B: mice on which TPA in acetone/DMSO was
applied on the ear
– group C: mice on which TPA in acetone/DMSO and
genistein (30 minutes later) were applied on the ear
– group D: mice on which TPA in acetone/DMSO and
genistein : HPBCD 1:2 (30 minutes later) were
applied on the ear
– group E: mice on which TPA in acetone/DMSO and
genistein : RAMEB 1:2 (30 minutes later) were
applied on the ear
– group F: mice on which TPA in acetone/DMSO and
indomethacin (30 minutes later) were applied on the
ear as control.
Inflammation protocol
Inflammation was induced in both ears of each mouse
by the topical application of 10 μg TPA dissolved in
0.1 ml acetone : DMSO in a molar ratio 9:1 to both the
inner and outer ear surfaces. Thirty minutes after the
application of TPA, the inner and outer surface of each
ear was treated with 2 mg of genistein, or the equivalent
quantity of 2 mg genistein corresponding from the com-
plex Gen : HPBCD and Gen : RAMEB. The same quan-
tity of indomethacin, 2 mg, was used as control. The
solvent was acetone : DMSO in a molar ratio 9:1 and
the quantity administered was 0.1 ml.[25,41] After 24
hours from the moment of application skin inflamma-
tion was induced, indicated by the increase of ear thick-
ness on C57BL6/J mice. Ear thickness was measured
with callipers, before treatment (value a) and 24 hours
after TPA application (value b =TPA alone and value c =
TPA+ active substance). The experiment was repeated
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deviation. The following values were also calculated:
– Oedema X induced by TPA alone (b-a),
– Oedema Y induced by TPA plus a sample (c-a),
– Inhibitory rate (%) [(Oedema X-Oedema Y)/Oedema
X] x 100.
After that, mice were killed by cervical dislocation and
6 mm2 diameter ear punch biopsies were collected and
H&E analysis was carried out [24,26]. The Prism soft-
ware package (Graph Pad Prism 4.03 for Windows) was
used for data presentation. The experiment was repeated
three times and results are presented as mean± SD.
Paired Student’s t tests was applied to evaluate statistical
significance (∗, p< 0.05; ∗∗, p< 0.01; and ∗∗∗,
p< 0.001).
Histology
For the histological analysis, tissue samples (skin) were
fixed in 10% formalin solution, embedded in paraffin
and cut at 4 microns. Finally, deparaffinized, the samples
were stained with H&E (hematoxylin-eosin) and micro-
scopically analysed. Immunohistochemistry was per-
formed by using CD45 antibodies against inflammatory
cells from the dermis. After dewaxing and rehydration,
the sections were incubated with CD45 for 30 minutes,
and then, the antigen-antibody reaction was detected by
using an avidin biotin system from Novocastra.
Visualization of the final product was done by using
3,3’diaminobenzidine as chromogen. Counterstain was
performed with Lille’s modified haematoxylin.
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